Press Releases

 
Press Releases
  Date Title View
Jun 22, 2016
TAMPA, Fla. and ALBANY, N.Y., June 22, 2016 /PRNewswire/ -- Teewinot Life Sciences Corporation (Teewinot) and Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced that AMRI has licensed Teewinot's technology to produce and sell the first commercially available cannabichromene acid (CBCA) analytical standard. The CBCA analytical standard i...
Jun 14, 2016
ALBANY, N.Y., June 14, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology Consortium  (CBC) Center for the Experimental Therapeutics (NExT) Program, centered at the Frederick National Laboratory for Cancer Research. The Frederick National Lab,...
May 23, 2016
ALBANY, N.Y., May 23, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 at 3:30 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relat...
May 10, 2016
ALBANY, N.Y., May 10, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) clarified its 2016 revenue guidance, following the company's first quarter earnings conference call held earlier this morning. The company expects approximately 50% of its 2016 revenue to be realized in the first half of the year and the corresponding 50% in the second half of th...
May 10, 2016
ALBANY, N.Y., May 10, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2016 and provided an update to its outlook for 2016. Highlights: First quarter contract revenue of $102.8 million, up 37% from 2015 First quarter royalties of $2.7 million, down 59...
May 9, 2016
ALBANY, N.Y., May 9, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has hired Louis Yu, Ph.D., to fill the newly created position of senior vice president of quality and compliance. Dr. Yu will report to William S. Marth, AMRI's president and CEO. Dr. Yu will oversee all aspects of quality and cGMP compliance at all divisions of A...
May 5, 2016
ALBANY, N.Y., May 5, 2016 /PRNewswire/ -- Enters definitive agreement to acquire Euticals for $358 million in stock, cash and a seller note Positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry Significantly expands AMRI's presence in the European community Transactio...
Apr 28, 2016
ALBANY, N.Y., April 28, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2016 financial results before the opening of the market on Tuesday, May 10, 2016.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can b...
Mar 30, 2016
ALBANY, N.Y., March 30, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the year ended December 31, 2015.  A copy of the Annual Report on Form 10-K is available to be viewed or downloaded within the Investor Relations section of the ...
Mar 14, 2016
ALBANY, N.Y., March 14, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has been recognized as a Life Science Leader CMO Leadership Award recipient in the categories of Expertise (overall, small pharma), Capabilities (small pharma) and Compatibility (small pharma). In 2013, AMRI was awarded a CMO Leadership Award in the Quality cat...
Page: FirstPrevious
3
... NextLast
= add release to Briefcase